Table 1.
Association between WNT2 IHC staining and patients’ clinicopathological parameters (n = 264)
| Total (n = 264) | High/median expression (n = 91) | Low/absent expression (n = 173) | x2 | P | |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 163 | 58 | 105 | 234 | 0.629 |
| Female | 101 | 33 | 68 | ||
| Age,y | |||||
| < 65 | 171 | 62 | 109 | 0.687 | 0.407 |
| ≥ 65 | 93 | 29 | 64 | ||
| Pathologic type | |||||
| ADC | 134 | 68 | 65 | 32.927 | < 0.0001 |
| Non-ADC | 130 | 23 | 108 | ||
| pT stage | |||||
| T1+T2 | 229 | 70 | 159 | 11.643 | 0.001 |
| T3+T4 | 35 | 21 | 14 | ||
| pN stage | |||||
| N0 | 28 | 6 | 22 | 2.358 | 0.125 |
| N1+N2 | 236 | 85 | 151 | ||
| Differentiation | |||||
| Well+Moderate | 177 | 58 | 119 | 0.688 | 0.407 |
| Poor | 87 | 33 | 54 |
P values were calculated by chi square test. ADC, adenocarcinoma.